Suppr超能文献

作为Toll样受体4(TLR4)抑制剂的抗炎α-和β-连接的乙酰氨基吡喃糖苷的合成。

Synthesis of -inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4).

作者信息

Wipf Peter, Eyer Benjamin R, Yamaguchi Yukihiro, Zhang Feng, Neal Matthew D, Sodhi Chhinder P, Good Misty, Branca Maria, Prindle Thomas, Lu Peng, Brodsky Jeffrey L, Hackam David J

机构信息

Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA ; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA.

出版信息

Tetrahedron Lett. 2015 Jun 3;56(23):3097-3100. doi: 10.1016/j.tetlet.2014.11.048.

Abstract

The low-molecular weight isopropyl 2-acetamido-α-glucoside (C34) inhibits toll-like receptor 4 (TLR4) in enterocytes and macrophages , and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis. We used a copper(II)-mediated solvolysis of anomeric oxazolines and an acid-mediated conversion of β-glucosamine and β-galactosamine pentaacetates to generate analogs of at the anomeric carbon and at C-4 of the pyranose ring. These compounds were evaluated for their influence on TLR4-mediated inflammatory signaling in cultured enterocytes and monocytes. Their efficacy was confirmed using a NF-kB-luciferase reporter mouse, thus establishing the first structure-activity relationship (SAR) study in this series and identifying the more efficacious isopropyl 2-acetamido-α-galactoside .

摘要

低分子量的2-乙酰氨基-α-葡萄糖苷异丙酯(C34)可抑制肠上皮细胞和巨噬细胞中的Toll样受体4(TLR4),并减轻内毒素血症和坏死性小肠结肠炎小鼠模型中的全身炎症。我们利用铜(II)介导的异头恶唑啉的溶剂解反应以及酸介导的β-葡萄糖胺和β-半乳糖胺五乙酸酯的转化反应,在吡喃糖环的异头碳和C-4位生成类似物。评估了这些化合物对培养的肠上皮细胞和单核细胞中TLR4介导的炎症信号传导的影响。使用NF-κB-荧光素酶报告基因小鼠证实了它们的功效,从而建立了该系列中的首个构效关系(SAR)研究,并确定了更有效的2-乙酰氨基-α-半乳糖苷异丙酯。

相似文献

1
Synthesis of -inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4).
Tetrahedron Lett. 2015 Jun 3;56(23):3097-3100. doi: 10.1016/j.tetlet.2014.11.048.
2
Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors.
PLoS One. 2013 Jun 12;8(6):e65779. doi: 10.1371/journal.pone.0065779. Print 2013.
3
Glycyrrhizin inhibits lipopolysaccharide-induced inflammatory response by reducing TLR4 recruitment into lipid rafts in RAW264.7 cells.
Biochim Biophys Acta. 2014 Jun;1840(6):1755-64. doi: 10.1016/j.bbagen.2014.01.024. Epub 2014 Jan 23.
7
TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Eur J Pharmacol. 2008 Apr 14;584(1):40-8. doi: 10.1016/j.ejphar.2008.01.026. Epub 2008 Feb 5.
10
CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8391-6. doi: 10.1073/pnas.1424980112. Epub 2015 Jun 23.

引用本文的文献

1
Biomolecules Increase Glycolysis and Invasive Potential in Lung Adenocarcinoma.
Cancers (Basel). 2025 Jan 24;17(3):380. doi: 10.3390/cancers17030380.
2
Digging deeper into necrotizing enterocolitis: bridging clinical, microbial, and molecular perspectives.
Gut Microbes. 2025 Dec;17(1):2451071. doi: 10.1080/19490976.2025.2451071. Epub 2025 Jan 18.
3
An anti-eCIRP strategy for necrotizing enterocolitis.
Mol Med. 2024 Sep 20;30(1):156. doi: 10.1186/s10020-024-00935-3.
4
Chromatin as alarmins in necrotizing enterocolitis.
Front Immunol. 2024 May 31;15:1403018. doi: 10.3389/fimmu.2024.1403018. eCollection 2024.
5
Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis.
Rheumatology (Oxford). 2024 Mar 1;63(3):608-618. doi: 10.1093/rheumatology/kead493.
6
Necrotizing enterocolitis: recent advances in treatment with translational potential.
Pediatr Surg Int. 2023 May 29;39(1):205. doi: 10.1007/s00383-023-05476-0.
7
Human milk oligosaccharides reduce necrotizing enterocolitis-induced neuroinflammation and cognitive impairment in mice.
Am J Physiol Gastrointest Liver Physiol. 2023 Jul 1;325(1):G23-G41. doi: 10.1152/ajpgi.00233.2022. Epub 2023 Apr 25.
8
Necrotizing enterocolitis: Bench to bedside approaches and advancing our understanding of disease pathogenesis.
Front Pediatr. 2023 Jan 11;10:1107404. doi: 10.3389/fped.2022.1107404. eCollection 2022.
10
Precision-based modeling approaches for necrotizing enterocolitis.
Dis Model Mech. 2020 Jun 24;13(6):dmm044388. doi: 10.1242/dmm.044388.

本文引用的文献

1
Euodenine A: a small-molecule agonist of human TLR4.
J Med Chem. 2014 Feb 27;57(4):1252-75. doi: 10.1021/jm401321v. Epub 2014 Feb 7.
2
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
J Med Chem. 2014 May 8;57(9):3612-22. doi: 10.1021/jm401006s. Epub 2013 Nov 20.
4
Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors.
PLoS One. 2013 Jun 12;8(6):e65779. doi: 10.1371/journal.pone.0065779. Print 2013.
5
New developments in Toll-like receptor targeted therapeutics.
Curr Opin Pharmacol. 2012 Aug;12(4):510-8. doi: 10.1016/j.coph.2012.06.002. Epub 2012 Jun 28.
6
Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.
J Biol Chem. 2012 May 11;287(20):16121-31. doi: 10.1074/jbc.M112.348383. Epub 2012 Mar 20.
7
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
Sci Signal. 2012 Feb 14;5(211):ra13. doi: 10.1126/scisignal.2001963.
8
Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.
J Med Chem. 2011 Oct 27;54(20):7268-79. doi: 10.1021/jm2008419. Epub 2011 Oct 5.
9
Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.
J Mol Cell Cardiol. 2012 Mar;52(3):538-49. doi: 10.1016/j.yjmcc.2011.08.009. Epub 2011 Aug 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验